EdgeMarketInstruments › PHGE

PHGE — BiomX Inc.

US Healthcare Pharma & biotech equity mkt cap 3.7M
0.14 -1.57% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.14 · high 11.97

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2019-03-13.

Performance

1 day-1.57%
1 week-6.46%
1 month-30.66%
3 months-81.39%
6 months-97.31%
Year to date-93.57%
1 year-98.61%
3 years-99.80%
5 years-99.98%

Technicals

RSI 1423.7
vs 50-day avg-49.52%
vs 200-day avg-94.90%
Volatility 1y201.7%
Max drawdown 1y-98.86%
Avg volume 30d1.6M
Daily bars held1,872
History from2019-03-13

Measured signals that fired on PHGE

datesignal measured base rate
2026-07-07Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-04-13Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-03-17Yeganeh Reuven
Director
Open-market sale530.0K5.002.6M
2026-03-17Yeganeh Reuven
Director
Conversion530.0K2.001.1M
2026-03-16Yeganeh Reuven
Director
Open-market sale450.0K5.002.2M
2026-03-16Yeganeh Reuven
Director
Conversion450.0K2.00900.0K
2026-03-13Yeganeh Reuven
Director
Open-market sale370.0K5.001.9M
2026-03-13Yeganeh Reuven
Director
Conversion370.0K2.00740.0K
2026-03-12Yeganeh Reuven
Director
Open-market sale300.0K5.001.5M
2026-03-11Yeganeh Reuven
Director
Conversion300.0K2.00600.0K
2025-04-14Bassan Merav
Chief Development Officer
Grant or award79.6K0.000
2025-04-14Solomon Jonathan Eitan
Chief Executive Officer
Grant or award126.7K0.000

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
DEERFIELD MANAGEMENT COMPANY, L.P.492.8K131.3K
Nantahala Capital Management, LLC430.9K114.8K
Ikarian Capital, LLC73.1K19.5K
MORGAN STANLEY71.7K19.1K
JPMORGAN CHASE & CO63.5K14.1K
JANE STREET GROUP, LLC44.4K11.8K
BARCLAYS PLC4.9K1.3K
UBS Group AG2.2K573
ROYAL BANK OF CANADA1.0K251
OSAIC HOLDINGS, INC.750200

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-192026-06-30on EDGAR ↗
NT 10-Q2026-08-142026-06-30on EDGAR ↗
SCHEDULE 13G/A2026-08-14on EDGAR ↗
SCHEDULE 13G/A2026-08-13on EDGAR ↗
8-K2026-08-112026-08-05on EDGAR ↗
DEF 14A2026-08-112026-08-25on EDGAR ↗
8-K2026-07-282026-07-27on EDGAR ↗
424B52026-07-27on EDGAR ↗

Short selling

Avg short volume, 90d39.9% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about PHGE

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open PHGE in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →